161 related articles for article (PubMed ID: 11160613)
1. Regional differences in anandamide- and methanandamide-induced membrane potential changes in rat mesenteric arteries.
Vanheel B; Van de Voorde J
J Pharmacol Exp Ther; 2001 Feb; 296(2):322-8. PubMed ID: 11160613
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens.
Ross RA; Gibson TM; Brockie HC; Leslie M; Pashmi G; Craib SJ; Di Marzo V; Pertwee RG
Br J Pharmacol; 2001 Feb; 132(3):631-40. PubMed ID: 11159715
[TBL] [Abstract][Full Text] [Related]
3. A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery.
White R; Hiley CR
Br J Pharmacol; 1997 Dec; 122(8):1573-84. PubMed ID: 9422801
[TBL] [Abstract][Full Text] [Related]
4. Studies on the effects of anandamide in rat hepatic artery.
Zygmunt PM; Högestätt ED; Waldeck K; Edwards G; Kirkup AJ; Weston AH
Br J Pharmacol; 1997 Dec; 122(8):1679-86. PubMed ID: 9422814
[TBL] [Abstract][Full Text] [Related]
5. Influence of cannabinoids on the delayed rectifier in freshly dissociated smooth muscle cells of the rat aorta.
Van den Bossche I; Vanheel B
Br J Pharmacol; 2000 Sep; 131(1):85-93. PubMed ID: 10960073
[TBL] [Abstract][Full Text] [Related]
6. Mesenteric vasodilation mediated by endothelial anandamide receptors.
Wagner JA; Varga K; Járai Z; Kunos G
Hypertension; 1999 Jan; 33(1 Pt 2):429-34. PubMed ID: 9931142
[TBL] [Abstract][Full Text] [Related]
7. Hypotensive effect of anandamide through the activation of CB1 and VR1 spinal receptors in urethane-anesthetized rats.
del Carmen García M; Adler-Graschinsky E; Celuch SM
Naunyn Schmiedebergs Arch Pharmacol; 2003 Oct; 368(4):270-6. PubMed ID: 14504685
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid activation of recombinant and endogenous vanilloid receptors.
Ralevic V; Kendall DA; Jerman JC; Middlemiss DN; Smart D
Eur J Pharmacol; 2001 Jul; 424(3):211-9. PubMed ID: 11672565
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries.
White R; Ho WS; Bottrill FE; Ford WR; Hiley CR
Br J Pharmacol; 2001 Oct; 134(4):921-9. PubMed ID: 11606334
[TBL] [Abstract][Full Text] [Related]
10. Methanandamide hyperpolarizes gastric arteries by stimulation of TRPV1 receptors on perivascular CGRP containing nerves.
Breyne J; Vanheel B
J Cardiovasc Pharmacol; 2006 Feb; 47(2):303-9. PubMed ID: 16495770
[TBL] [Abstract][Full Text] [Related]
11. Anandamide-induced relaxation of sheep coronary arteries: the role of the vascular endothelium, arachidonic acid metabolites and potassium channels.
Grainger J; Boachie-Ansah G
Br J Pharmacol; 2001 Nov; 134(5):1003-12. PubMed ID: 11682448
[TBL] [Abstract][Full Text] [Related]
12. A role for N-arachidonylethanolamine (anandamide) as the mediator of sensory nerve-dependent Ca2+-induced relaxation.
Ishioka N; Bukoski RD
J Pharmacol Exp Ther; 1999 Apr; 289(1):245-50. PubMed ID: 10087011
[TBL] [Abstract][Full Text] [Related]
13. Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein dependent and independent.
Mukhopadhyay S; Chapnick BM; Howlett AC
Am J Physiol Heart Circ Physiol; 2002 Jun; 282(6):H2046-54. PubMed ID: 12003810
[TBL] [Abstract][Full Text] [Related]
14. Effects of chronic nitric oxide synthase inhibition on the cardiovascular responses to cannabinoids in vivo and in vitro.
Wheal AJ; Bennett T; Randall MD; Gardiner SM
Br J Pharmacol; 2007 Mar; 150(5):662-71. PubMed ID: 17245361
[TBL] [Abstract][Full Text] [Related]
15. Evidence that anandamide and EDHF act via different mechanisms in rat isolated mesenteric arteries.
Plane F; Holland M; Waldron GJ; Garland CJ; Boyle JP
Br J Pharmacol; 1997 Aug; 121(8):1509-11. PubMed ID: 9283682
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.
Járai Z; Wagner JA; Varga K; Lake KD; Compton DR; Martin BR; Zimmer AM; Bonner TI; Buckley NE; Mezey E; Razdan RK; Zimmer A; Kunos G
Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14136-41. PubMed ID: 10570211
[TBL] [Abstract][Full Text] [Related]
17. Comparative pharmacology of endothelium-derived hyperpolarizing factor and anandamide in rat isolated mesentery.
Randall MD; McCulloch AI; Kendall DA
Eur J Pharmacol; 1997 Aug; 333(2-3):191-7. PubMed ID: 9314035
[TBL] [Abstract][Full Text] [Related]
18. R+-methanandamide inhibits tracheal response to endogenously released acetylcholine via capsazepine-sensitive receptors.
Nieri P; Martinotti E; Testai L; Adinolfi B; Calderone V; Breschi MC
Eur J Pharmacol; 2003 Jan; 459(1):75-81. PubMed ID: 12505536
[TBL] [Abstract][Full Text] [Related]
19. Anandamide and methanandamide induce both vanilloid VR1- and cannabinoid CB1 receptor-mediated changes in heart rate and blood pressure in anaesthetized rats.
Malinowska B; Kwolek G; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 2001 Dec; 364(6):562-9. PubMed ID: 11770012
[TBL] [Abstract][Full Text] [Related]
20. Long-term inhibition of nitric oxide synthase potentiates effects of anandamide in the rat mesenteric bed.
Mendizábal VE; Orliac ML; Adler-Graschinsky E
Eur J Pharmacol; 2001 Sep; 427(3):251-62. PubMed ID: 11567656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
